Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Fezziwig2008 Free

07/23/20 7:30 AM

Post #4

BRRGF BGBIO
in addition to COVID, Bemcentinib studied in Solid Cancer- NSCLC, GBM , etc - similar results just read out for AXL Blocker - Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500 in Platinum Resistant $BRRGF

Fezziwig2008 Free

07/20/20 7:54 AM

Post #3

Bergenbio Announces First Patient Dosed in Recurrent Glioblastoma Investigator Sponsored Phase I/II Study Assessing Selective AXL Inhibitor Bemcentinib https://www.biospace.com/article/releases/bergenbio-announces-first-patient-dosed-in-recurrent-glioblastoma-investigator-sponsored-phase-i-ii-study-assessing-selective-axl-inhibitor-bemcentinib/

Fezziwig2008 Free

07/16/20 5:42 AM

Post #2

BGBIO BRRGF Sharply Up on a Red day

Fezziwig2008 Free

07/12/20 5:11 PM

Post #1

BergenBio Bemcentinib # 1 Drug in U.K. COVID19 Accelerated ACCORD Trial (AZN has #2,3) - CEO says it has “an 80% chance of working.” Now 1/2 way till readout it’s being combined with Remdesivir and Decadron,
as an indication it’s working. I’m the only liquidity on the OTC board.